English Overview
In this lecture, Prof Torsten Witte will share recent up-to-date recommendations and best practices on the use of JAK inhibitors for patients affected by Rheumatoid Arthritis. Highlighting on its efficacy and tolerability with patients.
This Activity for
- Resident / Fellow
- Physician
What I will learn?
1. To present the recent results on JAK Inhibitors' efficacy and safety in the management of patients with Rheumatoid Arthritis.
2. To discuss the value of JAK inhibition through real-life clinical cases in Rheumatoid Arthritis.
3. To share up-to-date Rheumatoid Arthritis recommendations and evidence supporting the use of JAK Inhibitors in the management of Rheumatoid Arthritis.
2. To discuss the value of JAK inhibition through real-life clinical cases in Rheumatoid Arthritis.
3. To share up-to-date Rheumatoid Arthritis recommendations and evidence supporting the use of JAK Inhibitors in the management of Rheumatoid Arthritis.
Additional items to the activity
| Optional Details | Type | Fee |
|---|---|---|
|
Real-World Evidence of JAK Inhibitors in Rheumatoid Arthritis Certificate
Certificate |
Certificate | Free |
VAT 15% Included
